COPD Treatment
Links shared publicly online about this topic
New, Collaborative COPD Treatment Guidelines
copd.about.com — “New, Collaborative COPD Treatment Guidelines” View full resource at copd.about.com
Most Recently Shared on August 18, 2011 at 8:05 pm By:
Deborah Trendel-Lead New, Collaborative COPD Treatment Guidelines: Four physician organizations -- the American ... http://t.co/2a13IyT
COPD Treatments and Management to Improve Your Lifestyle
webmd.com — “COPD treatment: It's about improving your quality of life. Get control of your COPD symptoms with these treatment options.” View full resource at webmd.com
Most Recently Shared on September 13, 2011 at 8:35 pm By:
American Lung Utah Health Organization
Have COPD? Or know someone who does? Read about some tips to improve quality of life while living with COPD http://t.co/zSFE8ov
New COPD Treatment: Blood Pressure Medication? |
decodedscience.com — “Losartan, a common blood-pressure drug, may help prevent and treat lung damage from tobacco smoke, providing a boon to COPD sufferers.” View full resource at decodedscience.com
Most Recently Shared on December 20, 2011 at 2:03 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
New COPD Treatment: Blood Pressure Medication? | http://t.co/2VLZwPsm
Study identifies new target for asthma and COPD treatment
european-lung-foundation.org — “A new study has identified a molecule in the body that leads to inflammation and restructure in the airways, which contributes to a number of lung conditions including chronic asthma and chronic ...” View full resource at european-lung-foundation.org
Most Recently Shared on April 20, 2011 at 5:45 pm By:
Rick Frea Patient Expert and Health Professional
Study identifies new target for asthma and COPD treatment http://t.co/inaIz4x via @AddThis
COPD Condition Information, COPD Treatment Information and COPD Support Group
healthcentral.com — “Find information on COPD Treatment and COPD Management; Find support for COPD caregivers and patients” View full resource at healthcentral.com
Most Recently Shared on July 13, 2010 at 5:37 pm By:
COPD management and support groups: http://bit.ly/9AkA4S
Getting a Head Start on COPD Treatment | www.dailyrx.com
dailyrx.com — “Getting a Head Start on COPD Treatment | www.dailyrx.com” View full resource at dailyrx.com
Most Recently Shared on April 12, 2012 at 3:50 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Getting a Head Start on COPD Treatment http://t.co/v5Z8Qe4D
COPD Treatment a Clinical Trial Success | www.dailyrx.com
dailyrx.com — “COPD Treatment a Clinical Trial Success | www.dailyrx.com” View full resource at dailyrx.com
Most Recently Shared on December 11, 2011 at 2:08 am By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Glycopyrrolate had positive results in phase 2b clinical trials in COPD http://t.co/yrC4IhB2
Novartis cleared by EC for a COPD treatment - MarketWatch
marketwatch.com — “TEL AVIV (MarketWatch) -- Novartis, the Basel drugmaker, said on Thursday that the European Commission approved Onbrez in 150- and 300-microgram doses as a once-daily bronchodilator treatment for airflow obstruction in adults who suffer from chronic obstructive pulmonary disease. The product contains the active ingredient indacaterol maleate, Novartis said. COPD, which impairs lung function and causes chronic breathlessness, affects 210 million people worldwide and as many as 82 million of them ” View full resource at marketwatch.com
Most Recently Shared on December 3, 2009 at 4:09 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Novartis cleared by EC for a COPD treatment http://is.gd/5bfub
Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment
news-medical.net — “Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.” View full resource at news-medical.net
Most Recently Shared on March 20, 2012 at 6:39 am By:
Asthma News: Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment: Novartis Pharmaceuticals C... http://t.co/fD1L9Pfa
Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment
news-medical.net — “Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.” View full resource at news-medical.net
Most Recently Shared on March 20, 2012 at 10:07 am By:
OrganizedWisdom COPD OW Health
Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment: Novartis Pharmaceuticals Corporation to... http://t.co/c8Ld4yBK
New COPD Treatments Needed, Expert Says : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on November 28, 2011 at 9:33 pm By:
Bob Finn - Medical News Net Health News
Current treatments for chronic obstructive pulmonary disease can leave many patients with unmet needs - http://t.co/baaJ0Ez5
Nycomed Announces REACT Study To Evaluate Impact Of Daxas(R) (roflumilast) In Patients Receiving Standard COPD Treatment
medicalnewstoday.com — “Nycomed announced plans for an international phase III/IV study investigating the effect of Daxas® (500mcg tablets, once daily) versus placebo on exacerbation rates in COPD patients who are co” View full resource at medicalnewstoday.com
Most Recently Shared on March 30, 2011 at 4:05 pm By:
Nycomed Announces REACT Study To Evaluate Impact Of Daxas(R) (roflumilast) In Patients Receiving Standard COPD Treatment http://mnt.to/3SVT
Virtual lung models set to personalise asthma and COPD treatment - QualityPoint Technologies
qualitypointtech.net — “University of Leicester leads international project to develop pioneering tool A team of international experts, led by a University of Leicester researcher based at Glenfield Hospital, is set to develop a pioneering tool to help tailor the treatment of asthma and chronic obstructive pulmonary disease (COPD) as part of a new EU project.” View full resource at qualitypointtech.net
Most Recently Shared on May 19, 2011 at 10:00 am By:
Virtual lung models set to personalise asthma and COPD treatment: University of Leicester leads international proj... http://bit.ly/joPoq2
Novartis Faces Questions About Safety Of COPD Treatment | Markets | Minyanville.com
minyanville.com — “The company hopes to win approval for two dosing levels of inhaler for chronic disease. Safety concerns may trip up the panel of government advisers next week.” View full resource at minyanville.com
Most Recently Shared on March 5, 2011 at 6:28 am By:
Bart & Tara Health Organization
Novartis prepares for FDA meet on new #COPD medicine, Arcapta http://t.co/CM92ybG
Medical News: Early-Stage COPD Treatment Justified, Researchers Say - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “Treatment with the long-acting inhaled bronchodilator tiotropium (Spiriva) appears to be beneficial for patients with early-stage chronic obstructive pulmonary disease, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on August 28, 2009 at 3:28 pm By:
Use of long-acting bronchodilator tiotropium (Spiriva) appears to be beneficial for patients with early-stage COPD. http://bit.ly/gAysb
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
AboutCOPD
RN, freelance health writer, journalist, medical writer, passionate about COPD, About.com Guide to COPD
-
American Lung Utah
Committed to preventing lung disease and promoting lung health through education, research, and advocacy here in Utah and nationwide.
-
Michael Blaiss, MD
Allergist. Past President of the American College of Allergy, Asthma, and Immunology
Advertisement
